Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Spark Therapeutics
Spark Therapeutics
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy
Xconomy
Mon, 02/25/19 - 10:00 am
Roche
gene therapy
Spark Therapeutics
M&A
This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why
Investors Business Daily
Sun, 02/10/19 - 01:48 pm
uniQure
M&A
hemophilia B
AMT-061
Pfizer
Spark Therapeutics
Uniqure turns the screw on Spark and Pfizer
EP Vantage
Fri, 02/8/19 - 11:37 am
uniQure
Spark Therapeutics
Pfizer
AMT-061
hemophilia B
JPM19: Spark looks at scale, manufacturing as gene therapy matures
Biopharma Dive
Thu, 01/10/19 - 08:45 pm
JPMHC 2019
Spark Therapeutics
gene therapy
Luxturna
2 Sets of Disasters Biotech Will Pay For in 2019
Yahoo/Motley Fool
Mon, 12/17/18 - 12:16 am
Gilead Sciences
Yescarta
Novartis
Kymriah
Spark Therapeutics
Luxturna
Luxturna cleared for sale in Europe, but payer support uncertain
Biopharma Dive
Mon, 11/26/18 - 11:15 pm
Spark Therapeutics
Luxturna
Europe
gene therapy
Novartis/Spark’s sight gene therapy approved in EU
Pharmaforum
Fri, 11/23/18 - 01:16 pm
Novartis
Spark Therapeutics
Luxturna
gene therapy
Europe
Spark's CSO is wrapping up animal studies on a gene therapy for Pompe disease as new work in the field sees explosive growth
Endpoints
Mon, 10/8/18 - 10:58 pm
Spark Therapeutics
Pompe disease
SPK-3006
Spark/Novartis eye gene therapy nears EU market – but at what price?
Pharmaforum
Sun, 09/23/18 - 10:36 pm
Spark Therapeutics
Novartis
Luxturna
gene therapy
Europe
Express Scripts staking out million-dollar gene therapies
Reuters
Wed, 08/15/18 - 10:32 pm
Express Scripts
PBMs
gene therapies
drug pricing
Biomarin
Bluebird Bio
Spark Therapeutics
What's Next for Spark Therapeutics
Motley Fool
Wed, 08/15/18 - 09:50 am
Spark Therapeutics
hemophilia
SPK-8011
3 Beaten-Down Biotech Stocks: Can They Recover?
Motley Fool
Sun, 08/12/18 - 01:03 pm
Idera
Spark Therapeutics
Tesaro
7 companies to watch during Q2 earnings
Biopharma Dive
Sun, 07/22/18 - 12:41 pm
earnings
Biogen
Gilead Sciences
Amgen
Celgene
AbbVie
Pfizer
Spark Therapeutics
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Tue, 07/3/18 - 11:04 am
Spark Therapeutics
Zogenix
Progenics Pharmaceuticals
SPK-8011
ZX008
Azedra
FDA
Is biopharma’s first $1.5M therapy now in Phase III?
Endpoints
Mon, 05/7/18 - 11:12 am
drug pricing
gene therapy
Luxturna
Spark Therapeutics
Sparks sells regulatory fast pass to Jazz for $110M
Biopharma Dive
Mon, 04/30/18 - 09:02 pm
Spark Therapeutics
Jazz Pharmaceuticals
priority review vouchers
‘That’s $425,000 right there’ — the anxious launch of a gene therapy with a record sticker price
Stat
Wed, 03/21/18 - 09:23 am
gene therapy
drug pricing
drug launches
Luxturna
Spark Therapeutics
Spark lays groundwork for US Luxturna launch
Biopharma Dive
Wed, 02/21/18 - 10:58 pm
Spark Therapeutics
Luxturna
drug launches
gene therapy
Cost over sight? Spark's blindness cure has the industry talking
Medical Marketing and Media
Fri, 02/2/18 - 09:23 am
Spark Therapeutics
drug pricing
Luxturna
Novartis move signals further gene therapy resurgence
EP Vantage
Fri, 01/26/18 - 11:12 am
Novartis
gene therapy
Spark Therapeutics
CAR-T
Luxturna
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »